z-logo
Premium
Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis
Author(s) -
Knowles Helen J,
Athanasou Nicholas A
Publication year - 2009
Publication title -
the journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.964
H-Index - 184
eISSN - 1096-9896
pISSN - 0022-3417
DOI - 10.1002/path.2534
Subject(s) - osteoclast , bone resorption , resorption , cathepsin k , endocrinology , apoptosis , cathepsin , medicine , trypan blue , chemistry , hypoxia (environmental) , acid phosphatase , tunel assay , biology , biochemistry , enzyme , receptor , organic chemistry , oxygen
Osteoclasts are the primary mediators of pathological bone resorption in many conditions in which micro‐environmental hypoxia is associated with disease progression. However, effects of hypoxia on human osteoclast activity have not been reported. Mature human osteoclasts were differentiated from peripheral blood or obtained from giant cell tumour of bone. Osteoclasts were exposed to a constant hypoxic environment and then assessed for parameters including resorption (toluidine blue staining of dentine slices), membrane integrity (trypan blue exclusion), apoptosis (TUNEL, DAPI), and osteolysis‐associated enzyme activity (TRAP, cathepsin K). 24 h exposure to 2% O 2 produced a 2.5‐fold increase in resorption associated with increased TRAP and cathepsin K enzyme activity. Hypoxia‐Inducible Factor‐1α (HIF‐1α) siRNA completely ablated the hypoxic increase in osteoclast resorption. 24 h at 2% O 2 also increased the number of osteoclasts with compromised membrane integrity from 6% to 21%, with no change in the total osteoclast number or the proportion of late‐stage apoptotic cells. Transient reoxygenation returned the percentage of trypan blue‐positive cells to normoxic levels, suggesting that osteoclasts can recover from the early stages of cell death. Repeated over an extended period, hypoxia/reoxygenation enhanced osteoclast differentiation at this p O 2 . These data suggest that in diseased bone, where the p O 2 may fall to ≤2% O 2 , a delicate balance between hypoxia‐induced osteoclast activation and hypoxia‐induced osteoclast apoptosis mediates pathological bone resorption. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here